European Patent for Hypertension Management Using Wearable Device
Summary
The European Patent Office published patent application EP2024111722A1 filed by Meta Therapeutics Inc. on April 15, 2026, covering a system for providing hypertension management services using a wearable device with health monitoring sensors. This publication establishes prior art and creates intellectual property rights in the specified field across designated EPO member states including Germany, France, Italy, the Netherlands, and the United Kingdom. Competitors in digital health and medical device sectors should conduct freedom-to-operate analyses and monitor this application as it progresses through the examination process.
“SYSTEM FOR PROVIDING HYPERTENSION MANAGEMENT SERVICE BY USING WEARABLE DEVICE”
About this source
GovPing monitors EPO Patent Bulletin - Health Informatics (G16H) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 57 changes logged to date.
What changed
The European Patent Office published a new patent application (EP2024111722A1) for a system enabling hypertension management through wearable devices. The application includes 31 IPC classifications spanning health informatics (G16H), cardiovascular measurement (A61B 5/021), and physiological sensors. Meta Therapeutics Inc. is named as the applicant.
Competitors developing wearable health monitoring technologies, digital hypertension platforms, or related medical devices should assess freedom-to-operate implications. The publication constitutes prior art as of April 15, 2026, affecting subsequent patent applications in overlapping technical fields.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
SYSTEM FOR PROVIDING HYPERTENSION MANAGEMENT SERVICE BY USING WEARABLE DEVICE
Publication EP2024111722A1 Kind: A1 Apr 15, 2026
Applicants
Meta Therapeutics Inc.
Inventors
The designation of the inventor has not yet been filed
IPC Classifications
G16H 50/20 20180101AFI20240531BHEP G16H 10/60 20180101ALI20240531BHEP G16H 50/70 20180101ALI20240531BHEP G16H 20/70 20180101ALI20240531BHEP G16H 50/50 20180101ALI20240531BHEP A61B 5/021 20060101ALI20240531BHEP A61B 5/00 20060101ALI20240531BHEP A61B 5/16 20060101ALI20240531BHEP A61B 5/01 20060101ALI20240531BHEP A61B 5/08 20060101ALI20240531BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Health Informatics (G16H)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Health Informatics (G16H) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.